User profiles for Hicham Skali
Hicham Skali, MD, MScBrigham and Women's Hospital Verified email at post.harvard.edu Cited by 12790 |
Influence of ejection fraction on cardiovascular outcomes in a broad spectrum of heart failure patients
Background— Left ventricular function is a principal determinant of cardiovascular risk in
patients with heart failure. The growing number of patients with preserved systolic function …
patients with heart failure. The growing number of patients with preserved systolic function …
Right ventricular dysfunction and risk of heart failure and mortality after myocardial infarction
Objectives : The aim of this study was to determine the prognostic value of right ventricular (RV)
function in patients after a myocardial infarction (MI). Background : Right ventricular …
function in patients after a myocardial infarction (MI). Background : Right ventricular …
Influence of nonfatal hospitalization for heart failure on subsequent mortality in patients with chronic heart failure
SD Solomon, J Dobson, S Pocock, H Skali… - Circulation, 2007 - Am Heart Assoc
Background— Patients with chronic heart failure (HF) are at increased risk of both fatal and
nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart …
nonfatal major adverse cardiovascular events. We used data from the Candesartan in Heart …
[HTML][HTML] Moving beyond the hazard ratio in quantifying the between-group difference in survival analysis
In a longitudinal clinical study to compare two groups, the primary end point is often the time
to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely …
to a specific event (eg, disease progression, death). The hazard ratio estimate is routinely …
Cardiac positron emission tomography enhances prognostic assessments of patients with suspected cardiac sarcoidosis
…, P Kazemian, RY Kwong, M Tokuda, H Skali… - Journal of the American …, 2014 - jacc.org
Objectives : This study sought to relate imaging findings on positron emission tomography (PET)
to adverse cardiac events in patients referred for evaluation of known or suspected …
to adverse cardiac events in patients referred for evaluation of known or suspected …
Two‐Dimensional Assessment of Right Ventricular Function: An Echocardiographic–MRI Correlative Study
Background: While echocardiography is used most frequently to assess right ventricular (RV)
function in clinical practice, echocardiography is limited in its ability to provide an accurate …
function in clinical practice, echocardiography is limited in its ability to provide an accurate …
Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and …
Background— In individuals without known cardiovascular disease, elevated body mass
index (BMI) (weight/height 2 ) is associated with an increased risk of death. However, in …
index (BMI) (weight/height 2 ) is associated with an increased risk of death. However, in …
Changes in ventricular size and function in patients treated with valsartan, captopril, or both after myocardial infarction
SD Solomon, H Skali, NS Anavekar, M Bourgoun… - Circulation, 2005 - Am Heart Assoc
Background— Angiotensin-converting enzyme (ACE) inhibitors have been shown to attenuate
left ventricular (LV) enlargement in association with reducing mortality after myocardial …
left ventricular (LV) enlargement in association with reducing mortality after myocardial …
Prognostic implications of left ventricular mass and geometry following myocardial infarction: the VALIANT (VALsartan In Acute myocardial iNfarcTion) …
A Verma, A Meris, H Skali, JK Ghali, JMO Arnold… - JACC: Cardiovascular …, 2008 - jacc.org
Objectives : This study sought to understand prognostic implications of increased baseline
left ventricular (LV) mass and geometric patterns in a high risk acute myocardial infarction. …
left ventricular (LV) mass and geometric patterns in a high risk acute myocardial infarction. …
Effect of candesartan on cause-specific mortality in heart failure patients: the Candesartan in Heart failure Assessment of Reduction in Mortality and morbidity (CHARM …
Background— Patients with heart failure are at increased risk of sudden death and death
attributed to progressive pump failure. We assessed the effect of candesartan on cause-…
attributed to progressive pump failure. We assessed the effect of candesartan on cause-…